0 CHECKOUT

PRODUCT FILTERS

REGION

15
2
1
1
1

COUNTRY

1
1

CATEGORIES

  • 16
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

2
14
21
44

PUBLISHED

0
1
4
44

PRODUCT TYPE

28
14
2

Search for: "European Non-Hodgkin's Lymphoma Therapeutics Markets"

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020

Summary: This report provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises...

Published:  October 2014
Price:  From

Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011

Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011" provides data on the Non-Hodgkin...

Published:  November 2011
Price:  From

Lymphoma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million The report provides separate comprehensive analytics for US, Europe, and Rest of World Annual estimates and forecasts...

Published:  April 2010
Price:  From

The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

“The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis ” The report provides in-depth analysis of unmet needs, drivers and barriers...

Published:  December 2009
Price:  From

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain...

Published:  August 2014
Price:  From

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market Summary GBI Research, the leading business intelligence...

Published:  January 2011
Price:  From

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)

Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products.  Kalorama Information’s Stem Cell Therapeutics Markets is...

Published:  October 2014
Price:  From

Micromet's blinatumomab: a first-in-class bispecific antibody

On January 26th, Amgen announced the acquisition of Micromet, based on the promise of blinatumomab and the BiTE technology platform In this report, we review the blinatumomab program, the regulatory...

Published:  January 2012
Price:  From

Multiple Myeloma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

Published:  October 2011
Price:  From

Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019)

Nuclear medicine market is estimated to reach US$1.69 Billion by 2015. Radiopharmaceuticals/ Nuclear are drugs that contain radionuclide-emitting ionization radiation, used in the nuclear imaging...

Published:  August 2015
Price:  From

Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report

This report analyzes the Global market for Anti-CD20 Monoclonal Antibodies in US$ Million Annual estimates and forecasts are provided for the period 2006 through 2015 The report profiles 38 companies...

Published:  July 2010
Price:  From

Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success

This is a unique and unrivalled 367-page report analysing the performance of numerous important early stage oncology drug candidates, assessing their market viability based on preclinical scientific...

Published:  November 2006
Price:  From

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

Published:  January 2016
Price:  From

Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies....

Published:  January 2012
Price:  From

The Top 70 Western European Oncology Contract Research Organisations

It is estimated that clinical development expenditures outsourced by pharmaceutical, medical device and biotechnology companies worldwide in 2012 was approximately Euro 20 6 billion With greatly developed...

Published:  July 2013
Price:  From

Non-Hodgkin Lymphoma - Pipeline Review, Q4 2010

Non-Hodgkin Lymphoma - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Non-Hodgkin Lymphoma Pipeline Review, Q4 2010”, provides an overview of the Non-Hodgkin Lymphoma therapeutic pipeline....

Published:  December 2010
Price:  From

Radiopharmaceuticals - Global Strategic Business Report

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The report provides...

Published:  March 2015
Price:  From

Cell Therapeutics, Inc. - Product Pipeline Review - 2012

Cell Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Cell Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Cell...

Published:  August 2012
Price:  From

Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012

Accentia Biopharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012” provides...

Published:  September 2012
Price:  From

The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition

This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents...

Published:  January 2012
Price:  From
Loading Indicator

Our Clients

  • Ikea Systems B.V.
  • GlaxoSmithKline PLC
  • BT Group PLC.
  • Philips N.V.
  • BSH Home Appliances Ltd
  • Foreign & Commonwealth Office